← All trials
NCT00417716
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2005
- Primary completion
- —
- Completion date
- May 1, 2006
- First posted
- —
- Last posted
- —
- Enrollment
- 45
- Arms / groups
- — / —
- Source
- AACT · pre-existing
Sponsors
- Asociación para Evitar la Ceguera en MéxicoLead sponsor
- Asociación para Evitar la Ceguera en MéxicoOverall official - principal investigator
- Asociación para Evitar la Ceguera en MéxicoStudy director
- Asociación para Evitar la Ceguera en MéxicoStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.